Abstract:Abstract Background: The gene coding the Cu/Zn superoxide dismutase (SOD1) was the first-identified causative gene of amyotrophic lateral sclerosis (ALS), and the second most common genetic cause for ALS worldwide. The promising therapeutic approaches targeting SOD1 mutations are on the road. The purpose of the present study was to compare the mutational and clinical features of Chinese and German patients with ALS carrying mutations in SOD1 gene, which will facilitate the strategy and design of SOD1-targeted trials. Methods: Demographic and clinical characteristics were collected from two longitudinal cohorts in China and Germany. Chinese and German patients carrying SOD1 mutations were compared with regard to mutational distribution, age of onset, site of onset, body mass index (BMI) at diagnosis, diagnostic delay, progression rate, and survival. Results: A total of 66 Chinese and 84 German patients with 69 distinct SOD1 mutations were identified. The most common mutation in both populations was p.His47Arg. It was found in 8 Chinese and 2 German patients and consistently showed a slow progression of disease in both countries. Across all mutations, Chinese patients showed a younger age of onset (43.9 vs 49.9 years, p=0.002), a higher proportion of young-onset cases (62.5% vs 30.7%, p<0.001) and a lower BMI at diagnosis (22.8 vs 26.0, p<0.001) compared to German patients. Although riluzole intake was less frequent in Chinese patients (28.3% vs 81.3%, p<0.001), no difference in survival between populations was observed (p=0.90). Across both cohorts, female patients had a longer diagnostic delay (15.0 vs 11.0 months, p=0.01) and a prolonged survival (248.0 vs 60.0 months, p=0.005) compared to male patients. Conclusions: Our data demonstrate the distinct mutational and clinical spectrums of SOD1-mutant patients in Asian and European populations. Clinical phenotypes seem to be primarily influenced by mutation-specific, albeit not excluding ethnicity-specific factors. Further large-scale transethnical studies are needed to clarify determinants and modifiers of SOD1 phenotypes.

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history

Corrigendum to "Plasma superoxide dismutase activity in relation to disability in activities of daily living and objective physical functioning among Chinese older adults" [Maturitas, Volume 161, July 2022, Pages 12-17].

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

SOD1 Mutation Spectrum and Natural History of ALS Patients in a 15-Year Cohort in Southeastern China

Erratum: Genetic analysis of Down syndrome-associated heart defects in mice (Human Genetics DOI: 10.1007/s00439-011-0980-2)

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

A Natural History Comparison of SOD1-mutant Patients with Amyotrophic Lateral Sclerosis Between Chinese and German Populations

[Screening of Mutations in SOD1 Gene and Analysis of Genotype-Phenotype Correlation in Chinese Patients with Amyotrophic Lateral Sclerosis].

The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice

Association Between Superoxide Dismutase 1 Mutations and Clinical Phenotypes in Chinese Patients with Familial Amyotrophic Lateral Sclerosis

Genotype-phenotype Correlations in a Chinese Population with Familial Amyotrophic Lateral Sclerosis.

Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

A novel 10-base pair insertion mutation in exon 5 of the SOD1 gene in a Chinese family with amyotrophic lateral sclerosis

Identification of a Novel Missense (C7W) Mutation of SOD1 in a Large Familial Amyotrophic Lateral Sclerosis Pedigree

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Correction to: MGUS Predicts Worse Prognosis in Patients with CoronaryArtery Disease

A Rare Cu/Zn Superoxide Dismutase Mutation Causing Familial Amyotrophic Lateral Sclerosis with Variable Age of Onset and Incomplete Penetrance in China.

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

Identification and Functional Analysis of Novel Mutations in the SOD1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.